The global pharmaceutical and biotechnology industry is experiencing a period of accelerated growth in drug use and spending, driven by...

Brazil’s innovation ecosystem, while promising and showing significant progress, faces a persistent challenge in effectively converting...

In June 2025, the US Food and Drug Administration approved a new HIV pre-exposure prophylaxis (PrEP) regimen: the long-acting injectable...